More Pro and Con Arguments about IPIX: Pro: Brilacidin has never failed a clinical trial Regional BioLab Testing confirms stellar in vitro results of Brilacidin for Covid-19 and other viruses Received Fast Track Designation by FDA Phase 2 International Trial now greater than 70% enrollment Brilacidin has shown three (3) MOAs in vitro to destroy Covid, including modulate immune system and address secondary bacterial infections Company has millions in the bank Top line results coming in July Con: Leo has "baby brains" Leo hasn’t released Board of Director meeting notes Leo has neglected shareholder communications Brilacidin could be another Prurisol Leo is diluting the company for “lifestyle reasons” Leo is in a “desperate situation”
Market Data 
Markets
AI
